期刊文献+

瘦素及脂联素在消化系统肿瘤中的研究进展 被引量:2

Progress of leptin and adiponectin in digestive system neoplasms
原文传递
导出
摘要 作为心脑血管疾病、癌症、糖尿病等慢性病的重要诱因,肥胖已被世界卫生组织列为继心脑血管疾病和癌症之后威胁人类健康的第三大敌人。近年来的研究结果显示,肥胖与结直肠癌、食管癌、肾癌和子宫内膜癌等许多肿瘤的发生相关。但其导致肿瘤发生风险增加的机制尚未完全揭示。瘦素、脂联素是脂肪组织分泌的一类激素,参与机体能量代谢,在影响肿瘤生长的多个环节日益受到重视。 As an important incentive for cardiovascular disease, cancer, diabetes and other chronic diseases, obesity after cardiovascular disease and cancer has been listed as the third largest threat to human health by World Health Organization. Recent research has shown that obesity is associated with coloreetal cancer, esophageal cancer, kidney cancer, endometrial cancer, however, it has not been fully disclosed that the mechanism could lead to an increased risk of tumors. Leptin and adiponectin are a kind of hormone secreted by adipose tissue, which involve in the energy metabolism, and play an increasing significant role in the tumors" affecting factors.
作者 李杨 刘亚航(综述) 郭瑞芳(审校) Li Yang Liu Yahang Guo Ruifang(Postgraduate College, Inner Mongolia Medical University, Huhhot 010110, China Department of Thyroid Tumor Surgery, the People's Hospital of lnner Mongolia Autonomous Region, Huhhot 010017, China Clinical Nutrition Center, the People ~s Hospital of Inner Mongolia Autonomous Region, Huhhot 010017, China)
出处 《肿瘤研究与临床》 CAS 2016年第12期858-861,共4页 Cancer Research and Clinic
基金 内蒙古自治区自然科学基金(2016MS0870) 内蒙古自治区人民医院科研基金(201502)
关键词 瘦素 脂联素 消化系统肿瘤 Leptin Adiponectin Digestive system neoplasms
  • 相关文献

参考文献1

二级参考文献23

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 2Kamangar F, Dotes GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14) :2137-2150.
  • 3Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Imcet, 2013, 381 (9864) :400-412.
  • 4Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets [J]. Cancer Epidemiol, 2011, 35(4):309-319.
  • 5Kubo A, Codey DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis [ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15 ( 5 ) :872-878.
  • 6Navarre Silvem SA, Mayne ST, Risch HA, et al. Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer [ J ]. Ann Epidemiol, 2011, 21 (7) :543-550.
  • 7Kavanagh ME, O'Sullivan KE, O'Hanlon C, et al. The esophagitis to adenocarcinoma sequence; the role of inflammation [ J ]. Cancer Lett, 2014, 345(2) :182-189.
  • 8Kendall B J, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus[J]. Gut, 2008, 57(4) :448-454.
  • 9Rubenstein JH, Dahlkemper A, Kan JY, et al. A pilot study of the association of low plasma adiponectin and Barrett's esophagus [J]. Am J Gastreenterol, 2008, 103(6) :1358-1364.
  • 10Kato M, Watabe K, Hamasaki T, et al. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups[J]. J Gastroenterol,2011,46(12):1361-1367.

共引文献4

同被引文献14

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部